Therefore, we undertook this study to definitively identify the cellular source(s) of ARG1 in human NSCLC, to determine whether TANs possessed the ability to produce ARG1 de novo, and to uncover the operative mechanisms involved in ARG1 production and function in this context. Here, ARG1 is linked to non-small cell lung carcinoma.